Bloomberg News

Scientist Who Led Genentech to Avastin Joins Tiziana as Adviser

May 19, 2014

Napoleone Ferrara, professor at UC San Diego School of Medicine, joins Tiziana Life Sciences as chairman of scientific advisory board and consultant, co. says in statement. * Co. developing experimental treatment for late-stage breast cancer targeting BCL3 gene * “I look forward to advising the company’s scientists as they work towards human trials for this promising therapeutic gene technology”: Ferrara * NOTE: Tiziana started trading on AIM on April 24 * NOTE: Ferrara in 2010 won Lasker Award, which often foretells future Nobel Prize winners * NOTE: Avastin for colorectal, breast, lung, kidney, ovarian cancers and glioblastoma had CHF6.25b ($7b) in sales last yr

To contact the reporter on this story: Makiko Kitamura in London at mkitamura1@bloomberg.net

To contact the editors responsible for this story: Phil Serafino at pserafino@bloomberg.net Kristen Hallam, Tom Lavell


Race, Class, and the Future of Ferguson
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

 
blog comments powered by Disqus